DAVITA INC. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
DAVITA INC. (DVA) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Notes › and Others
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2021-02-12
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2017-12-31 was $37.76M.
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2017-09-30 was -$19.59M.
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2017-06-30 was -$1.54M.
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2017-03-31 was -$9.59M, a 156.96% decline year-over-year.
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2020 was $0.00.
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2018 was $7.30M, a 3.80% increase from fiscal 2017.
- DAVITA INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2017 was $7.03M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-12 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-02-12 | ||||
| 2018-12-31 | $7.30M 10-K · filed 2021-02-12 | ||||
| 2017-12-31 | $37.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $18.17M derived: sum of 2 quarters · filed 2020-02-21 | $16.63M derived: sum of 3 quarters · filed 2020-02-21 | $7.03M 10-K · filed 2020-02-21 | -$20.50M 10-K · filed 2018-02-23 |
| 2017-09-30 | -$19.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$21.13M derived: sum of 2 quarters · filed 2017-11-07 | -$30.73M 10-Q · filed 2017-11-07 | -$31.01M derived: sum of 4 quarters · filed 2018-02-23 | |
| 2017-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$11.14M 10-Q · filed 2017-08-01 | -$11.42M derived: sum of 3 quarters · filed 2018-02-23 | -$39.26M derived: sum of 4 quarters · filed 2018-02-23 | |
| 2017-03-31 | -$9.59M 10-Q · filed 2017-05-02 | -$9.88M derived: sum of 2 quarters · filed 2018-02-23 | -$37.72M derived: sum of 3 quarters · filed 2018-02-23 | -$39.27M derived: sum of 4 quarters · filed 2018-02-23 | |
| 2016-12-31 | -$286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$28.12M derived: sum of 2 quarters · filed 2018-02-23 | -$29.68M derived: sum of 3 quarters · filed 2018-02-23 | -$12.84M 10-K · filed 2018-02-23 | -$12.09M 10-K · filed 2017-02-24 |
| 2016-09-30 | -$27.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$29.39M derived: sum of 2 quarters · filed 2016-11-02 | -$12.55M 10-Q · filed 2016-11-02 | -$10.26M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2016-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $15.29M 10-Q · filed 2016-08-08 | $17.58M derived: sum of 3 quarters · filed 2017-02-24 | $13.63M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2016-03-31 | $16.84M 10-Q · filed 2016-05-04 | $19.14M derived: sum of 2 quarters · filed 2017-02-24 | $15.19M derived: sum of 3 quarters · filed 2017-02-24 | $25.84M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$1.65M derived: sum of 2 quarters · filed 2017-02-24 | $9.00M derived: sum of 3 quarters · filed 2017-02-24 | $21.47M 10-K · filed 2017-02-24 | |
| 2015-09-30 | -$3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $6.70M derived: sum of 2 quarters · filed 2015-11-05 | $19.18M 10-Q · filed 2015-11-05 | $26.66M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2015-06-30 | $10.65M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-05 | $23.12M 10-Q · filed 2015-08-05 | $30.61M derived: sum of 3 quarters · filed 2016-02-26 | $20.92M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2015-03-31 | $12.47M 10-Q/A · filed 2015-05-08 | $19.95M derived: sum of 2 quarters · filed 2016-02-26 | $10.27M derived: sum of 3 quarters · filed 2016-02-26 | $8.04M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$2.20M derived: sum of 2 quarters · filed 2016-02-26 | -$4.43M derived: sum of 3 quarters · filed 2016-02-26 | $5.53M 10-K · filed 2016-02-26 | |
| 2014-09-30 | -$9.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$11.92M derived: sum of 2 quarters · filed 2014-11-06 | -$1.95M 10-Q · filed 2014-11-06 | $13.59M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2014-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $7.74M 10-Q · filed 2014-08-01 | $23.28M derived: sum of 3 quarters · filed 2015-02-26 | $15.13M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2014-03-31 | $9.96M 10-Q · filed 2014-05-02 | $25.51M derived: sum of 2 quarters · filed 2015-02-26 | $17.36M derived: sum of 3 quarters · filed 2015-02-26 | $7.44M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-12-31 | $15.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $7.40M derived: sum of 2 quarters · filed 2015-02-26 | -$2.53M derived: sum of 3 quarters · filed 2015-02-26 | -$7.98M 10-K · filed 2015-02-26 | |
| 2013-09-30 | -$8.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$18.07M derived: sum of 2 quarters · filed 2013-11-06 | -$23.52M 10-Q · filed 2013-11-06 | -$46.96M derived: sum of 4 quarters · filed 2014-02-21 | |
| 2013-06-30 | -$9.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$15.38M 10-Q · filed 2013-08-07 | -$38.81M derived: sum of 3 quarters · filed 2014-02-21 | -$23.45M derived: sum of 4 quarters · filed 2014-02-21 | |
| 2013-03-31 | -$5.45M 10-Q · filed 2013-05-09 | -$28.89M derived: sum of 2 quarters · filed 2014-02-21 | -$13.53M derived: sum of 3 quarters · filed 2014-02-21 | ||
| 2012-12-31 | -$23.44M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | -$8.08M derived: sum of 2 quarters · filed 2014-02-21 | -$5.22M 10-K · filed 2014-02-21 | ||
| 2012-09-30 | $15.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $18.22M 10-Q · filed 2012-10-31 | |||
| 2012-06-30 | $2.86M 10-Q · filed 2012-08-03 | ||||
| 2011-12-31 | $14.71M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |